SCHEMBL1433252

SCHEMBL1433252

O=C(O)C1CCC2(CCNCC2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
GRM2 Q14416 2/20 0.50
GRM3 Q14832 2/20 0.50
GRM4 Q14833 2/20 0.50
CYP2C19 P33261 2/20 0.50
LMNA P02545 2/20 0.50
CYP1A2 P05177 2/20 0.50
ALOX15 P16050 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
GRM8 O00222 1/20 0.50
GRM6 O15303 1/20 0.50
GRM5 P41594 1/20 0.50
MTOR P42345 1/20 0.50
GRM1 Q13255 1/20 0.50
PLCB1 Q9NQ66 1/20 0.50
GABRP O00591 1/20 0.50
GABRD O14764 1/20 0.50
GABRA1 P14867 1/20 0.50
GABRB1 P18505 1/20 0.50
GABRG2 P18507 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6620534 0.88 TSHR (0.60) TSHRGRM2GRM3GRM4CYP2C19
SCHEMBL18394460 0.85 CYP2C19 (0.61) TSHRGRM2GRM3GRM4CYP2C19
SCHEMBL25855066 0.85 CYP2C19 (0.59) TSHRGRM2GRM3GRM4CYP2C19
SCHEMBL9977512 0.85 CYP2C19 (0.59) TSHRGRM2GRM3GRM4CYP2C19
Hydrochloric Acid SCHEMBL29031078 0.83 CYP2C19 (0.58) TSHRGRM2GRM3GRM4CYP2C19
SCHEMBL11646566 0.83 CYP2C19 (0.62) TSHRGRM2GRM3GRM4CYP2C19
SCHEMBL12246944 0.82 TSHR (0.34) TSHRGRM2GRM3GRM4CYP2C19
SCHEMBL15557486 0.82 KDM4E (0.41) TSHRGRM2GRM3GRM4CYP2C19
SCHEMBL31506997 0.82 CYP2C19 (0.50) TSHRGRM2GRM3GRM4CYP2C19
SCHEMBL3021254 0.81 CYP2C19 (0.54) TSHRGRM2GRM3GRM4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020128608-A1 COMPOUND FOR USE IN A METHOD FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION ALTAVANT SCIENCES GMBH (CH) 2020-06-25 WO claimed
EP-3041842-A1 SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS Karos Pharmaceuticals, Inc. (US) 2016-07-13 EP disclosed
WO-2015035113-A1 SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS KAROS PHARMACEUTICALS, INC. (US) 2015-03-12 WO disclosed
EP-2300474-A1 SPIRO (PIPERIDINE-4, 2 ' -PYRROLIDINE) -1- (3, 5- TRIFLUOROMETHYL PHENYL) METHYLCARBOXAMIDES AS NK1 TACHIKYNIN RECEPTOR ANTAGONISTS Glaxo Wellcome Manufacturing Pte Ltd (SG) 2011-03-30 EP disclosed
WO-2009133135-A1 SPIRO (PIPERIDINE-4, 2 ' -PYRROLIDINE) -1- (3, 5- TRIFLUOROMETHYL PHENYL) METHYLCARBOXAMIDES AS NK1 TACHIKYNIN RECEPTOR ANTAGONISTS GLAXO WELLCOME MANUFACTURING PTE LTD (SG) 2009-11-05 WO disclosed